MHUA vs. ZYXI, RBOT, PETV, ECOR, MODD, MLSS, DRIO, COCH, POCI, and STRR
Should you be buying Meihua International Medical Technologies stock or one of its competitors? The main competitors of Meihua International Medical Technologies include Zynex (ZYXI), Vicarious Surgical (RBOT), PetVivo (PETV), electroCore (ECOR), Modular Medical (MODD), Milestone Scientific (MLSS), DarioHealth (DRIO), Envoy Medical (COCH), Precision Optics (POCI), and Star Equity (STRR). These companies are all part of the "medical equipment" industry.
Meihua International Medical Technologies vs. Its Competitors
Meihua International Medical Technologies (NASDAQ:MHUA) and Zynex (NASDAQ:ZYXI) are both small-cap medical companies, but which is the superior stock? We will contrast the two businesses based on the strength of their risk, earnings, valuation, institutional ownership, media sentiment, analyst recommendations, dividends and profitability.
Zynex has a consensus price target of $4.90, indicating a potential upside of 262.96%. Given Zynex's stronger consensus rating and higher possible upside, analysts clearly believe Zynex is more favorable than Meihua International Medical Technologies.
Meihua International Medical Technologies has higher earnings, but lower revenue than Zynex.
Meihua International Medical Technologies has a net margin of 0.00% compared to Zynex's net margin of -19.79%. Meihua International Medical Technologies' return on equity of 0.00% beat Zynex's return on equity.
Meihua International Medical Technologies has a beta of 0.75, suggesting that its stock price is 25% less volatile than the S&P 500. Comparatively, Zynex has a beta of 1.1, suggesting that its stock price is 10% more volatile than the S&P 500.
1.2% of Meihua International Medical Technologies shares are held by institutional investors. Comparatively, 29.7% of Zynex shares are held by institutional investors. 66.6% of Meihua International Medical Technologies shares are held by company insiders. Comparatively, 49.3% of Zynex shares are held by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company will outperform the market over the long term.
In the previous week, Zynex had 2 more articles in the media than Meihua International Medical Technologies. MarketBeat recorded 4 mentions for Zynex and 2 mentions for Meihua International Medical Technologies. Meihua International Medical Technologies' average media sentiment score of 0.87 beat Zynex's score of 0.58 indicating that Meihua International Medical Technologies is being referred to more favorably in the media.
Summary
Zynex beats Meihua International Medical Technologies on 8 of the 14 factors compared between the two stocks.
Get Meihua International Medical Technologies News Delivered to You Automatically
Sign up to receive the latest news and ratings for MHUA and its competitors with MarketBeat's FREE daily newsletter.
New MarketBeat Followers Over Time
This chart shows the number of new MarketBeat users adding MHUA and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip ChartMedia Sentiment Over Time
This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart
Meihua International Medical Technologies Competitors List
Related Companies and Tools
This page (NASDAQ:MHUA) was last updated on 10/16/2025 by MarketBeat.com Staff